
Biomaterials Research, Journal Year: 2025, Volume and Issue: 29
Published: Jan. 1, 2025
Senescent chondrocytes, which are increased in osteoarthritic (OA) cartilage, promote cartilage defects and the senescent knee microenvironment by inducing senescence to surrounding normal chondrocytes secreting senescence-associated secretory proteins. Many studies have used mesenchymal stem cells (MSCs) treat OA, but MSC treatment remains challenging for clinical application owing quality control, engraftment, fibrocartilage regeneration. Here, rather than relying on direct regeneration of MSCs, we present a novel strategy suppress OA MSC-mediated chondrocyte targeting via paracrine activity thereby improving microenvironment. First, enable control umbilical cord priming MSCs supplementing human platelet lysate (hPL) greatly enhanced functions increasing cellular glutathione levels throughout serial passaging. Intra-articular injection primed successfully suppressed progression accumulation without Indirect coculture with using transwell ameliorated phenotypes suggesting rejuvenation. Based secretome analysis, identified insulin-like growth factor 2 (IGF2) as key component that induces rejuvenation MSCs. The effects IGF2 act through autophagy activation up-regulation autophagy-related gene expression autophagic flux. To cross-validate secreted vivo, knockdown substantially abolished its therapeutic efficacy rabbit model. Collectively, these findings demonstrate hPL supplementation enables levels. mechanism was IGF2, activating autophagy.
Language: Английский